COG-AALL1731
Phase III
OPEN TO ACCRUAL
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)